Literature DB >> 18689707

Variability of the standard reference height and its influence on the stereometric parameters of the heidelberg retina tomograph 3.

Christophe Breusegem1, Steffen Fieuws, Ingeborg Stalmans, Thierry Zeyen.   

Abstract

PURPOSE: To investigate the variability of the standard reference height (SRH) in consecutive Heidelberg Retina Tomograph 3 (HRT3) examinations and its influence on five main stereometric parameters.
METHODS: HRT3 results of all patients attending our glaucoma center from August to October 2007 were retrospectively reviewed. Only one eye per patient with at least three consecutive HRTs and a quality control label of acceptable or better was selected. An SRH difference >or=10% compared with baseline was considered as excess SRH variability.
RESULTS: A review of 641 patients yielded 150 patients (150 eyes) who met the inclusion criteria, representing a total of 556 examinations. The mean total number of HRTs per patient was 3.7 (range, 3-7), and the mean follow-up time was 3.5 years (range, 1.4-6.7). The mean proportion of consecutive HRT3 examinations with intraindividual excess SRH variability was 46% (95% CI, 40-52), whereas the mean intraindividual excess SRH variability was 24% (95% CI, 20-28). The median absolute SRH difference was 8.6% (interquartile range, 3.9%-16.2%). Furthermore, 55.5%, 75.3%, 74.7%, 0.0%, and 19.4% of the variability in rim area, rim volume, retinal nerve fiber layer thickness, cup shape measure, and height variation contour, respectively, could be attributed to SRH variability.
CONCLUSIONS: There is considerable SRH variability between HRT3 examinations of the same eye, and this could explain more than half the variability of the parameters RA, RV, and RNFL. These findings indicate that changes of HRT3 parameters should be considered with caution when excess SRH variability is present.

Entities:  

Mesh:

Year:  2008        PMID: 18689707     DOI: 10.1167/iovs.08-2331

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Glaucomatous progression in series of stereoscopic photographs and Heidelberg retina tomograph images.

Authors:  Neil O'Leary; David P Crabb; Steven L Mansberger; Brad Fortune; Michael D Twa; Michael J Lloyd; Aachal Kotecha; David F Garway-Heath; George A Cioffi; Chris A Johnson
Journal:  Arch Ophthalmol       Date:  2010-05

2.  A comparison of rates of change in neuroretinal rim area and retinal nerve fiber layer thickness in progressive glaucoma.

Authors:  Luciana M Alencar; Linda M Zangwill; Robert N Weinreb; Christopher Bowd; Pamela A Sample; Christopher A Girkin; Jeffrey M Liebmann; Felipe A Medeiros
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-05       Impact factor: 4.799

Review 3.  [Glaucoma diagnosis and follow-up using the Heidelberg Retina Tomograph].

Authors:  E M Hoffmann; J Lamparter; T Schmidt; A Schulze
Journal:  Ophthalmologe       Date:  2009-08       Impact factor: 1.059

4.  Glaucoma Diagnosis and Monitoring Using Advanced Imaging Technologies.

Authors:  Mitra Sehi; Shawn M Iverson
Journal:  US Ophthalmic Rev       Date:  2013

5.  Stereometric parameters change vs. Topographic Change Analysis (TCA) agreement in Heidelberg Retina Tomography III (HRT-3) early detection of clinical significant glaucoma progression.

Authors:  A M Dascalu; A P Cherecheanu; D Stana; L Voinea; R Ciuluvica; C Savlovschi; D Serban
Journal:  J Med Life       Date:  2014 Oct-Dec

6.  Inter-test reference height variability--a major error factor in Heidelberg Retina Tomography glaucoma progression analysis based on stereometric parameters changes.

Authors:  A M Dascalu; D Stana; S Duta; I S Ardeleanu; C Savlovschi; D Serban; A P Cherecheanu
Journal:  J Med Life       Date:  2014-09-25

7.  Morphometric Optic Nerve Head Analysis in Glaucoma Patients: A Comparison between the Simultaneous Nonmydriatic Stereoscopic Fundus Camera (Kowa Nonmyd WX3D) and the Heidelberg Scanning Laser Ophthalmoscope (HRT III).

Authors:  Siegfried Mariacher; Stephanie Hipp; Robert Wirthky; Gunnar Blumenstock; Karl-Ulrich Bartz-Schmidt; Focke Ziemssen; Ulrich Schiefer; Bogomil Voykov; Kai Januschowski
Journal:  J Ophthalmol       Date:  2016-05-30       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.